FDA OTC Funding Increase For ’04 Trimmed By House Appropriations Cmte.
This article was originally published in The Tan Sheet
Executive Summary
Funding for FDA nonprescription drug activities would increase $700,000 under the FY 2004 Agriculture Appropriations bill reported out of the House Appropriations Committee June 25
You may also be interested in...
FDA Announces “Proactive” Approach To Rx-To-OTC Switches
FDA plans to take a more active role in initiating Rx-to OTC switches in coming years, Senior Associate Commissioner for Management & Systems Jeff Weber said Feb. 3
Washington In Brief
Burton gets subcommittee chair: Former House Government Reform Committee Chair Dan Burton (R-Ind.) named to oversee newly created Subcommittee on Wellness & Human Rights, Committee Chair Tom Davis (R-Va.) announces Jan. 31. Subcommittee will address issues concerning public health policy, human rights and family health, according to Davis' office. Votes to confirm the subcommittee and chairman appointment will be taken when the full Government Reform Committee convenes, possibly the week of Feb. 10. In his new position, Burton likely will revisit dietary supplement-related issues, which were the subject of frequent hearings during his tenure as full committee chair...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC